Trevena
TRVN
$0.39
Share price
-4.40%
Change (1 day)
-39.85%
Change (1 year)
Categories
Trevena (TRVN) - Total assets
Total assets on the balance sheet as of September 2023 : $45.13 M
According to Trevena's latest financial reports the company's total assets are $45.13 M. A company’s total assets is the sum of all current and non-current assets, such as inventories, cash and cash equivalents, properties and equipment.
Trevena - Total assets on balance sheet (from 2012 to 2023)
Total assets by year
| Year | Total assets | Change |
|---|---|---|
| 2022-12-31 | $48.68 M | -39.24% |
| 2021-12-31 | $80.12 M | -37.28% |
| 2020-12-31 | $0.12 B | 171.82% |
| 2019-12-31 | $46.99 M | -29.63% |
| 2018-12-31 | $66.77 M | -8.17% |
| 2017-12-31 | $72.72 M | -36.57% |
| 2016-12-31 | $0.11 B | -34.62% |
| 2015-12-31 | $0.17 B | 62.01% |
| 2014-12-31 | $0.10 B | 155.32% |
| 2013-12-31 | $42.39 M | 424.17% |
| 2012-12-31 | $8.08 M | -58.33% |
| 2011-12-31 | $19.4 M |
Total Assets for similar companies or competitors
| Company | Total assets | differencediff. | Country |
|---|---|---|---|
 Amgen AMGN | $97.15 B | 215,161.56% | 🇺🇸 USA |
 Merck MRK | $106.67 B | 236,256.99% | 🇺🇸 USA |
 Flexion Therapeutics
FLXN | N/A | N/A | 🇺🇸 USA |
 Cytokinetics
CYTK | $0.82 B | 1,726.42% | 🇺🇸 USA |
 AcelRx Pharmaceuticals
ACRX | $20.39 M | -54.81% | 🇺🇸 USA |
 Cara Therapeutics
CARA | $0.12 B | 178.83% | 🇺🇸 USA |
 Arena Pharmaceuticals
ARNA | N/A | N/A | 🇺🇸 USA |